WG
NEOS

Winton Group’s Neos Therapeutics, Inc NEOS Stock Holding History

Winton Group’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-29,418
Closed -$22K – 1647
2020
Q1 		$22K Sell
29,418
-20,947
-42% -$28.8K ﹤0.01% 1369
2019
Q4 		$76K Sell
50,365
-38,707
-43% -$58.1K ﹤0.01% 1495
2019
Q3 		$132K Buy
+89,072
New +$144K ﹤0.01% 1436

Other funds holding NEOS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winton Group's NEOS Position: Q2 2020 in Review

Winton Group sold out of Neos Therapeutics, Inc (NEOS) in Q2 2020, closing a stake of 29,418 shares — an estimated $22K sold.

Winton Group first reported a position in NEOS in Q3 2019 and held it in 3 quarters. The position peaked at $132K in Q3 2019. 44 funds tracked by Wall St. Rank hold NEOS as of Q2 2020.

  • Winton Group reported no remaining Neos Therapeutics, Inc position as of Q2 2020 after selling out during the quarter.
  • Winton Group sold 29,418 Neos Therapeutics, Inc shares in Q2 2020, an estimated $22K.
  • Winton Group first reported a position in Neos Therapeutics, Inc in Q3 2019 and held it in 3 quarters.
  • Winton Group's Neos Therapeutics, Inc position peaked at $132K in Q3 2019.
  • 44 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2020.

Based on Winton Group's 13F filing for Q2 2020, filed 5 Aug 2020.